All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| CDNA / CareDx, Inc
|
|
|
|
|
|
|
|
| MTEM / Molecular Templates, Inc.
|
|
|
|
|
|
|
|
| EPIX / ESSA Pharma Inc.
|
|
|
|
|
|
|
|
| ICPT / Intercept Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| EVFM / Evofem Biosciences, Inc.
|
|
|
|
|
|
|
|
| EXAC / Exactech, Inc.
|
|
|
|
|
|
|
|
| CASC / Cascadian Therapeutics, Inc.
|
|
|
|
|
|
|
|
| LOXO / Loxo Oncology, Inc.
|
|
|
|
|
|
|
|
| ASPX / Auspex Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| SLS / SELLAS Life Sciences Group, Inc.
|
|
|
|
|
|
|
|
| 87611RAA6 / Targacept Inc Bond
|
|
|
|
|
|
|
|
| CLBS / Caladrius Biosciences Inc
|
|
|
|
|
|
|
|
| DERM / Journey Medical Corporation
|
|
|
|
|
|
|
|
| SGYPQ / SYNERGY PHARMACEUTICALS INC DEL
|
|
|
|
|
|
|
|
| ZSPH / ZS Pharma, Inc.
|
|
|
|
|
|
|
|
| EPZM / Epizyme Inc
|
|
|
|
|
|
|
|
| GNVC / GenVec, Inc.
|
|
|
|
|
|
|
|
| CLVS / Clovis Oncology Inc
|
|
|
|
|
|
|
|
| CYTR / LadRx Corp
|
|
|
|
|
|
|
|
| KERX / Keryx Biopharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ECIA / Encision Inc.
|
|
|
|
|
|
|
|
| JNJ / Johnson & Johnson
|
|
|
|
|
|
|
|
| AGTC / Applied Genetic Technologies Corp
|
|
|
|
|
|
|
|
| APEN / Apollo Endosurgery Inc
|
|
|
|
|
|
|
|
| NSPH / Nanosphere, Inc.
|
|
|
|
|
|
|
|
| 09074D103 / Biotie Therapies Corp.
|
|
|
|
|
|
|
|
| GBIM / GlobeImmune, Inc.
|
|
|
|
|
|
|
|
| IRONWOOD PHARMA
/ NOTE 2.25% 15-Jun-2022 144A SR UNSECURED CONV (46333XAC2) |
|
|
|
|
|
|
|
| TTHI / Transition Therapeutics Inc.
|
|
|
|
|
|
|
|
| CASM / CAS Medical Systems, Inc.
|
|
|
|
|
|
|
|
| 45784PAD3 / Insulet Corp. Bond
|
|
|
|
|
|
|
|
| RIOT / Riot Platforms, Inc.
|
|
|
|
|
|
|
|
| XNPT / XenoPort, Inc.
|
|
|
|
|
|
|
|
| WINT / Windtree Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NXTM / NxStage Medical, Inc.
|
|
|
|
|
|
|
|
| NVDQ / ETF Opportunities Trust - T-Rex 2X Inverse NVIDIA Daily Target ETF
|
|
|
|
|
|
|
|
| CEMI / Chembio Diagnostics Inc.
|
|
|
|
|
|
|
|
| ELOS / Syneron Medical Ltd.
|
|
|
|
|
|
|
|
| CUTR / Cutera, Inc.
|
|
|
|
|
|
|
|
| 670704AC9 / NuVasive, Inc. Bond
|
|
|
|
|
|
|
|
| DSCI / Derma Sciences, Inc.
|
|
|
|
|
|
|
|
| DXTR / Dextera Surgical Inc.
|
|
|
|
|
|
|
|
| NERV / Minerva Neurosciences, Inc.
|
|
|
|
|
|
|
|
| US74975N1054 / RTI Surgical, Inc.
|
|
|
|
|
|
|
|
| ACER / Acer Therapeutics Inc
|
|
|
|
|
|
|
|
| APTO / Aptose Biosciences Inc.
|
|
|
|
|
|
|
|
| LMNS / Lumenis Ltd
|
|
|
|
|
|
|
|
| 74365AAB7 / Protalix BioTherapeutics, Inc. Bonds 4.5% 9/15/18
|
|
|
|
|
|
|
|
| ATRS / Antares Pharma Inc
|
|
|
|
|
|
|
|
| ABIO / ARCA biopharma, Inc.
|
|
|
|
|
|
|
|
| CYAD / Celyad Oncology - ADR
|
|
|
|
|
|
|
|
| APYX / Apyx Medical Corporation
|
|
|
|
|
|
|
|
| CYNA / Cynapsus Therapeutics Inc.
|
|
|
|
|
|
|
|
| CHEK / Check-Cap Ltd.
|
|
|
|
|
|
|
|
| US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ZGNX / Zogenix Inc
|
|
|
|
|
|
|
|
| VSCI /
|
|
|
|
|
|
|
|
| CYNA / Cynapsus Therapeutics Inc.
|
|
|
|
|
|
|
|
| CYNA / Cynapsus Therapeutics Inc.
|
|
|
|
|
|
|
|
| US0906721065 / BioTelemetry, Inc.
|
|
|
|
|
|
|
|
| ALDX / Aldeyra Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SPNC / Spectranetics Corp. (The)
|
|
|
|
|
|
|
|
| TNXP / Tonix Pharmaceuticals Holding Corp.
|
|
|
|
|
|
|
|
| DRNA / Dicerna Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| PIRS / Pieris Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ALPN / Alpine Immune Sciences, Inc.
|
|
|
|
|
|
|
|
| CRBP / Corbus Pharmaceuticals Holdings, Inc.
|
|
|
|
|
|
|
|
| CHEK / Check-Cap Ltd.
|
|
|
|
|
|
|
|
| AERI / Aerie Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| ARNA / Arena Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| ABBV / AbbVie Inc.
|
|
|
|
|
|
|
|
| PLX / Protalix BioTherapeutics, Inc.
|
|
|
|
|
|
|
|
| CRIS / Curis, Inc.
|
|
|
|
|
|
|
|
| RIGL / Rigel Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| PCYC / Pharmacyclics
|
|
|
|
|
|
|
|
| MRNS / Marinus Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CVM / CEL-SCI Corporation
|
|
|
|
|
|
|
|
| MASI / Masimo Corporation
|
|
|
|
|
|
|
|
| FATE / Fate Therapeutics, Inc.
|
|
|
|
|
|
|
|
| OTIC / Otonomy Inc
|
|
|
|
|
|
|
|
| BLUE / bluebird bio, Inc.
|
|
|
|
|
|
|
|
| QURE / uniQure N.V.
|
|
|
|
|
|
|
|
| CARA / Cara Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ATNM / Actinium Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| AFMD / Affimed N.V.
|
|
|
|
|
|
|
|
| LPCN / Lipocine Inc.
|
|
|
|
|
|
|
|
| SCYX / SCYNEXIS, Inc.
|
|
|
|
|
|
|
|
| STXS / Stereotaxis, Inc.
|
|
|
|
|
|
|
|
| TNDM / Tandem Diabetes Care, Inc.
|
|
|
|
|
|
|
|
| ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| ATRC / AtriCure, Inc.
|
|
|
|
|
|
|
|
| PODD / Insulet Corporation
|
|
|
|
|
|
|
|
| BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
